nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—FPR1—bone marrow—osteoporosis	0.00539	0.274	CbGeAlD
Nedocromil—PTGDR—bone marrow—osteoporosis	0.00509	0.259	CbGeAlD
Nedocromil—CYSLTR1—uterus—osteoporosis	0.00266	0.135	CbGeAlD
Nedocromil—HSP90AA1—uterus—osteoporosis	0.0023	0.117	CbGeAlD
Nedocromil—CYSLTR1—bone marrow—osteoporosis	0.00225	0.115	CbGeAlD
Nedocromil—HSP90AA1—bone marrow—osteoporosis	0.00196	0.0995	CbGeAlD
Nedocromil—Asthenia—Ergocalciferol—osteoporosis	0.00186	0.00363	CcSEcCtD
Nedocromil—Rhinitis—Risedronate—osteoporosis	0.00185	0.00363	CcSEcCtD
Nedocromil—Arthritis—Estradiol—osteoporosis	0.00184	0.0036	CcSEcCtD
Nedocromil—Sinusitis—Pamidronate—osteoporosis	0.00184	0.0036	CcSEcCtD
Nedocromil—Pharyngitis—Risedronate—osteoporosis	0.00184	0.00359	CcSEcCtD
Nedocromil—Visual impairment—Ethinyl Estradiol—osteoporosis	0.00183	0.00358	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Conjugated Estrogens—osteoporosis	0.0018	0.00352	CcSEcCtD
Nedocromil—Cough—Estropipate—osteoporosis	0.00178	0.00348	CcSEcCtD
Nedocromil—Rhinitis—Pamidronate—osteoporosis	0.00176	0.00345	CcSEcCtD
Nedocromil—Conjunctivitis—Zoledronate—osteoporosis	0.00174	0.00341	CcSEcCtD
Nedocromil—Nausea—Calcium Acetate—osteoporosis	0.00174	0.00341	CcSEcCtD
Nedocromil—Cough—Raloxifene—osteoporosis	0.00172	0.00337	CcSEcCtD
Nedocromil—Chest pain—Alendronate—osteoporosis	0.00171	0.00335	CcSEcCtD
Nedocromil—Dyspepsia—Etidronic acid—osteoporosis	0.00169	0.00331	CcSEcCtD
Nedocromil—Chest pain—Raloxifene—osteoporosis	0.00168	0.00329	CcSEcCtD
Nedocromil—Chest pain—Ibandronate—osteoporosis	0.00166	0.00326	CcSEcCtD
Nedocromil—Anaphylactic shock—Estropipate—osteoporosis	0.00166	0.00326	CcSEcCtD
Nedocromil—Chest pain—Calcitriol—osteoporosis	0.00163	0.00319	CcSEcCtD
Nedocromil—Dry mouth—Ibandronate—osteoporosis	0.00163	0.00319	CcSEcCtD
Nedocromil—Sinusitis—Conjugated Estrogens—osteoporosis	0.00162	0.00316	CcSEcCtD
Nedocromil—Anaphylactic shock—Ibandronate—osteoporosis	0.0016	0.00312	CcSEcCtD
Nedocromil—Dry mouth—Calcitriol—osteoporosis	0.00159	0.00312	CcSEcCtD
Nedocromil—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00157	0.00308	CcSEcCtD
Nedocromil—Anaphylactic shock—Calcitriol—osteoporosis	0.00156	0.00306	CcSEcCtD
Nedocromil—Rhinitis—Conjugated Estrogens—osteoporosis	0.00155	0.00304	CcSEcCtD
Nedocromil—Influenza—Estradiol—osteoporosis	0.00155	0.00303	CcSEcCtD
Nedocromil—Nausea—Ergocalciferol—osteoporosis	0.00154	0.00301	CcSEcCtD
Nedocromil—Pharyngitis—Conjugated Estrogens—osteoporosis	0.00154	0.00301	CcSEcCtD
Nedocromil—Urticaria—Etidronic acid—osteoporosis	0.00153	0.00299	CcSEcCtD
Nedocromil—Abdominal pain—Etidronic acid—osteoporosis	0.00152	0.00298	CcSEcCtD
Nedocromil—Dysgeusia—Pamidronate—osteoporosis	0.0015	0.00294	CcSEcCtD
Nedocromil—Visual impairment—Conjugated Estrogens—osteoporosis	0.00149	0.00292	CcSEcCtD
Nedocromil—Bronchitis—Estradiol—osteoporosis	0.00149	0.00291	CcSEcCtD
Nedocromil—Dyspepsia—Estropipate—osteoporosis	0.00146	0.00287	CcSEcCtD
Nedocromil—Dyspepsia—Alendronate—osteoporosis	0.00144	0.00282	CcSEcCtD
Nedocromil—Cough—Ethinyl Estradiol—osteoporosis	0.00144	0.00282	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Estradiol—osteoporosis	0.00144	0.00281	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Estropipate—osteoporosis	0.00144	0.00281	CcSEcCtD
Nedocromil—Fatigue—Estropipate—osteoporosis	0.00143	0.00281	CcSEcCtD
Nedocromil—Pain—Estropipate—osteoporosis	0.00142	0.00278	CcSEcCtD
Nedocromil—Dyspepsia—Raloxifene—osteoporosis	0.00142	0.00278	CcSEcCtD
Nedocromil—Hypersensitivity—Etidronic acid—osteoporosis	0.00142	0.00277	CcSEcCtD
Nedocromil—Cough—Risedronate—osteoporosis	0.00141	0.00275	CcSEcCtD
Nedocromil—Dyspepsia—Ibandronate—osteoporosis	0.0014	0.00275	CcSEcCtD
Nedocromil—Pain—Alendronate—osteoporosis	0.0014	0.00274	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00139	0.00272	CcSEcCtD
Nedocromil—Pneumonia—Estradiol—osteoporosis	0.00139	0.00272	CcSEcCtD
Nedocromil—Pain—Raloxifene—osteoporosis	0.00138	0.0027	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00138	0.0027	CcSEcCtD
Nedocromil—Fatigue—Ibandronate—osteoporosis	0.00138	0.00269	CcSEcCtD
Nedocromil—Chest pain—Risedronate—osteoporosis	0.00137	0.00268	CcSEcCtD
Nedocromil—Leukopenia—Pamidronate—osteoporosis	0.00137	0.00268	CcSEcCtD
Nedocromil—Dysgeusia—Zoledronate—osteoporosis	0.00137	0.00268	CcSEcCtD
Nedocromil—Pain—Ibandronate—osteoporosis	0.00136	0.00267	CcSEcCtD
Nedocromil—Gastrointestinal pain—Estropipate—osteoporosis	0.00136	0.00266	CcSEcCtD
Nedocromil—Dry mouth—Risedronate—osteoporosis	0.00134	0.00263	CcSEcCtD
Nedocromil—Conjunctivitis—Estradiol—osteoporosis	0.00134	0.00262	CcSEcCtD
Nedocromil—Gastrointestinal pain—Alendronate—osteoporosis	0.00134	0.00262	CcSEcCtD
Nedocromil—Cough—Pamidronate—osteoporosis	0.00134	0.00262	CcSEcCtD
Nedocromil—Pain—Calcitriol—osteoporosis	0.00134	0.00261	CcSEcCtD
Nedocromil—Urticaria—Estropipate—osteoporosis	0.00132	0.00259	CcSEcCtD
Nedocromil—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00132	0.00258	CcSEcCtD
Nedocromil—Gastrointestinal pain—Raloxifene—osteoporosis	0.00132	0.00258	CcSEcCtD
Nedocromil—Diarrhoea—Etidronic acid—osteoporosis	0.00132	0.00258	CcSEcCtD
Nedocromil—Abdominal pain—Estropipate—osteoporosis	0.00131	0.00257	CcSEcCtD
Nedocromil—Body temperature increased—Estropipate—osteoporosis	0.00131	0.00257	CcSEcCtD
Nedocromil—Tremor—Zoledronate—osteoporosis	0.00131	0.00257	CcSEcCtD
Nedocromil—Gastrointestinal pain—Ibandronate—osteoporosis	0.0013	0.00255	CcSEcCtD
Nedocromil—Urticaria—Alendronate—osteoporosis	0.0013	0.00255	CcSEcCtD
Nedocromil—Body temperature increased—Alendronate—osteoporosis	0.0013	0.00254	CcSEcCtD
Nedocromil—Abdominal pain—Alendronate—osteoporosis	0.0013	0.00254	CcSEcCtD
Nedocromil—Sinusitis—Estradiol—osteoporosis	0.00129	0.00253	CcSEcCtD
Nedocromil—Gastrointestinal pain—Calcitriol—osteoporosis	0.00128	0.0025	CcSEcCtD
Nedocromil—Body temperature increased—Raloxifene—osteoporosis	0.00127	0.00249	CcSEcCtD
Nedocromil—Abdominal pain—Raloxifene—osteoporosis	0.00127	0.00249	CcSEcCtD
Nedocromil—Urticaria—Ibandronate—osteoporosis	0.00127	0.00248	CcSEcCtD
Nedocromil—Abdominal pain—Ibandronate—osteoporosis	0.00126	0.00247	CcSEcCtD
Nedocromil—Body temperature increased—Ibandronate—osteoporosis	0.00126	0.00247	CcSEcCtD
Nedocromil—Leukopenia—Zoledronate—osteoporosis	0.00125	0.00245	CcSEcCtD
Nedocromil—Anaphylactic shock—Pamidronate—osteoporosis	0.00125	0.00245	CcSEcCtD
Nedocromil—Rhinitis—Estradiol—osteoporosis	0.00124	0.00243	CcSEcCtD
Nedocromil—Urticaria—Calcitriol—osteoporosis	0.00124	0.00243	CcSEcCtD
Nedocromil—Abdominal pain—Calcitriol—osteoporosis	0.00123	0.00242	CcSEcCtD
Nedocromil—Body temperature increased—Calcitriol—osteoporosis	0.00123	0.00242	CcSEcCtD
Nedocromil—Pharyngitis—Estradiol—osteoporosis	0.00123	0.00241	CcSEcCtD
Nedocromil—Hypersensitivity—Estropipate—osteoporosis	0.00123	0.0024	CcSEcCtD
Nedocromil—Vomiting—Etidronic acid—osteoporosis	0.00122	0.00239	CcSEcCtD
Nedocromil—Cough—Zoledronate—osteoporosis	0.00122	0.00239	CcSEcCtD
Nedocromil—Rash—Etidronic acid—osteoporosis	0.00121	0.00237	CcSEcCtD
Nedocromil—Dermatitis—Etidronic acid—osteoporosis	0.00121	0.00237	CcSEcCtD
Nedocromil—Hypersensitivity—Alendronate—osteoporosis	0.00121	0.00236	CcSEcCtD
Nedocromil—Headache—Etidronic acid—osteoporosis	0.0012	0.00236	CcSEcCtD
Nedocromil—Asthenia—Estropipate—osteoporosis	0.00119	0.00234	CcSEcCtD
Nedocromil—Visual impairment—Estradiol—osteoporosis	0.00119	0.00234	CcSEcCtD
Nedocromil—Chest pain—Zoledronate—osteoporosis	0.00119	0.00233	CcSEcCtD
Nedocromil—Asthenia—Alendronate—osteoporosis	0.00118	0.0023	CcSEcCtD
Nedocromil—Hypersensitivity—Ibandronate—osteoporosis	0.00118	0.0023	CcSEcCtD
Nedocromil—Cough—Conjugated Estrogens—osteoporosis	0.00118	0.0023	CcSEcCtD
Nedocromil—Dyspnoea—Risedronate—osteoporosis	0.00117	0.00229	CcSEcCtD
Nedocromil—Dry mouth—Zoledronate—osteoporosis	0.00116	0.00228	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00116	0.00228	CcSEcCtD
Nedocromil—Fatigue—Ethinyl Estradiol—osteoporosis	0.00116	0.00228	CcSEcCtD
Nedocromil—Dyspepsia—Risedronate—osteoporosis	0.00116	0.00227	CcSEcCtD
Nedocromil—Hypersensitivity—Calcitriol—osteoporosis	0.00115	0.00225	CcSEcCtD
Nedocromil—Chest pain—Conjugated Estrogens—osteoporosis	0.00115	0.00224	CcSEcCtD
Nedocromil—Asthenia—Ibandronate—osteoporosis	0.00114	0.00224	CcSEcCtD
Nedocromil—Nausea—Etidronic acid—osteoporosis	0.00114	0.00224	CcSEcCtD
Nedocromil—Anaphylactic shock—Zoledronate—osteoporosis	0.00114	0.00223	CcSEcCtD
Nedocromil—Diarrhoea—Estropipate—osteoporosis	0.00114	0.00223	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Risedronate—osteoporosis	0.00113	0.00222	CcSEcCtD
Nedocromil—Fatigue—Risedronate—osteoporosis	0.00113	0.00222	CcSEcCtD
Nedocromil—Pain—Risedronate—osteoporosis	0.00112	0.0022	CcSEcCtD
Nedocromil—Diarrhoea—Alendronate—osteoporosis	0.00112	0.00219	CcSEcCtD
Nedocromil—Asthenia—Calcitriol—osteoporosis	0.00112	0.00219	CcSEcCtD
Nedocromil—Dyspnoea—Pamidronate—osteoporosis	0.00111	0.00218	CcSEcCtD
Nedocromil—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.0011	0.00216	CcSEcCtD
Nedocromil—Diarrhoea—Raloxifene—osteoporosis	0.0011	0.00216	CcSEcCtD
Nedocromil—Dyspepsia—Pamidronate—osteoporosis	0.0011	0.00215	CcSEcCtD
Nedocromil—Dizziness—Estropipate—osteoporosis	0.0011	0.00215	CcSEcCtD
Nedocromil—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.0011	0.00215	CcSEcCtD
Nedocromil—Diarrhoea—Ibandronate—osteoporosis	0.00109	0.00214	CcSEcCtD
Nedocromil—Dizziness—Alendronate—osteoporosis	0.00108	0.00212	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00108	0.00211	CcSEcCtD
Nedocromil—Fatigue—Pamidronate—osteoporosis	0.00108	0.00211	CcSEcCtD
Nedocromil—Gastrointestinal pain—Risedronate—osteoporosis	0.00107	0.0021	CcSEcCtD
Nedocromil—Urticaria—Ethinyl Estradiol—osteoporosis	0.00107	0.0021	CcSEcCtD
Nedocromil—Pain—Pamidronate—osteoporosis	0.00107	0.00209	CcSEcCtD
Nedocromil—Diarrhoea—Calcitriol—osteoporosis	0.00107	0.00209	CcSEcCtD
Nedocromil—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00107	0.00209	CcSEcCtD
Nedocromil—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00107	0.00209	CcSEcCtD
Nedocromil—Dizziness—Raloxifene—osteoporosis	0.00107	0.00209	CcSEcCtD
Nedocromil—Vomiting—Estropipate—osteoporosis	0.00106	0.00207	CcSEcCtD
Nedocromil—Dysgeusia—Estradiol—osteoporosis	0.00106	0.00207	CcSEcCtD
Nedocromil—Dizziness—Ibandronate—osteoporosis	0.00105	0.00206	CcSEcCtD
Nedocromil—Rash—Estropipate—osteoporosis	0.00105	0.00205	CcSEcCtD
Nedocromil—Dermatitis—Estropipate—osteoporosis	0.00105	0.00205	CcSEcCtD
Nedocromil—Urticaria—Risedronate—osteoporosis	0.00104	0.00204	CcSEcCtD
Nedocromil—Headache—Estropipate—osteoporosis	0.00104	0.00204	CcSEcCtD
Nedocromil—Vomiting—Alendronate—osteoporosis	0.00104	0.00204	CcSEcCtD
Nedocromil—Abdominal pain—Risedronate—osteoporosis	0.00104	0.00203	CcSEcCtD
Nedocromil—Body temperature increased—Risedronate—osteoporosis	0.00104	0.00203	CcSEcCtD
Nedocromil—Rash—Alendronate—osteoporosis	0.00103	0.00202	CcSEcCtD
Nedocromil—Dermatitis—Alendronate—osteoporosis	0.00103	0.00202	CcSEcCtD
Nedocromil—Headache—Alendronate—osteoporosis	0.00103	0.00201	CcSEcCtD
Nedocromil—Vomiting—Raloxifene—osteoporosis	0.00102	0.00201	CcSEcCtD
Nedocromil—Gastrointestinal pain—Pamidronate—osteoporosis	0.00102	0.002	CcSEcCtD
Nedocromil—Dyspnoea—Zoledronate—osteoporosis	0.00102	0.00199	CcSEcCtD
Nedocromil—Rash—Raloxifene—osteoporosis	0.00102	0.00199	CcSEcCtD
Nedocromil—Dermatitis—Raloxifene—osteoporosis	0.00101	0.00199	CcSEcCtD
Nedocromil—Vomiting—Ibandronate—osteoporosis	0.00101	0.00199	CcSEcCtD
Nedocromil—Tremor—Estradiol—osteoporosis	0.00101	0.00198	CcSEcCtD
Nedocromil—Headache—Raloxifene—osteoporosis	0.00101	0.00198	CcSEcCtD
Nedocromil—Rash—Ibandronate—osteoporosis	0.00101	0.00197	CcSEcCtD
Nedocromil—Dermatitis—Ibandronate—osteoporosis	0.001	0.00197	CcSEcCtD
Nedocromil—Dyspepsia—Zoledronate—osteoporosis	0.001	0.00197	CcSEcCtD
Nedocromil—Headache—Ibandronate—osteoporosis	0.000999	0.00196	CcSEcCtD
Nedocromil—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000993	0.00194	CcSEcCtD
Nedocromil—Vomiting—Calcitriol—osteoporosis	0.000993	0.00194	CcSEcCtD
Nedocromil—Nausea—Estropipate—osteoporosis	0.000988	0.00193	CcSEcCtD
Nedocromil—Body temperature increased—Pamidronate—osteoporosis	0.000988	0.00193	CcSEcCtD
Nedocromil—Abdominal pain—Pamidronate—osteoporosis	0.000988	0.00193	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000985	0.00193	CcSEcCtD
Nedocromil—Rash—Calcitriol—osteoporosis	0.000985	0.00193	CcSEcCtD
Nedocromil—Fatigue—Zoledronate—osteoporosis	0.000984	0.00193	CcSEcCtD
Nedocromil—Dermatitis—Calcitriol—osteoporosis	0.000984	0.00193	CcSEcCtD
Nedocromil—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00098	0.00192	CcSEcCtD
Nedocromil—Headache—Calcitriol—osteoporosis	0.000978	0.00191	CcSEcCtD
Nedocromil—Pain—Zoledronate—osteoporosis	0.000976	0.00191	CcSEcCtD
Nedocromil—Nausea—Alendronate—osteoporosis	0.000973	0.0019	CcSEcCtD
Nedocromil—Hypersensitivity—Risedronate—osteoporosis	0.000968	0.0019	CcSEcCtD
Nedocromil—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000967	0.00189	CcSEcCtD
Nedocromil—Asthenia—Ethinyl Estradiol—osteoporosis	0.000967	0.00189	CcSEcCtD
Nedocromil—Nausea—Raloxifene—osteoporosis	0.000957	0.00187	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000949	0.00186	CcSEcCtD
Nedocromil—Fatigue—Conjugated Estrogens—osteoporosis	0.000948	0.00185	CcSEcCtD
Nedocromil—Nausea—Ibandronate—osteoporosis	0.000947	0.00185	CcSEcCtD
Nedocromil—Asthenia—Risedronate—osteoporosis	0.000943	0.00185	CcSEcCtD
Nedocromil—Cough—Estradiol—osteoporosis	0.000941	0.00184	CcSEcCtD
Nedocromil—Pain—Conjugated Estrogens—osteoporosis	0.00094	0.00184	CcSEcCtD
Nedocromil—Gastrointestinal pain—Zoledronate—osteoporosis	0.000933	0.00183	CcSEcCtD
Nedocromil—Nausea—Calcitriol—osteoporosis	0.000927	0.00182	CcSEcCtD
Nedocromil—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000922	0.00181	CcSEcCtD
Nedocromil—Hypersensitivity—Pamidronate—osteoporosis	0.000921	0.0018	CcSEcCtD
Nedocromil—Chest pain—Estradiol—osteoporosis	0.000918	0.0018	CcSEcCtD
Nedocromil—Urticaria—Zoledronate—osteoporosis	0.000907	0.00178	CcSEcCtD
Nedocromil—Abdominal pain—Zoledronate—osteoporosis	0.000902	0.00177	CcSEcCtD
Nedocromil—Body temperature increased—Zoledronate—osteoporosis	0.000902	0.00177	CcSEcCtD
Nedocromil—Diarrhoea—Risedronate—osteoporosis	0.000899	0.00176	CcSEcCtD
Nedocromil—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000899	0.00176	CcSEcCtD
Nedocromil—Dry mouth—Estradiol—osteoporosis	0.000897	0.00176	CcSEcCtD
Nedocromil—Asthenia—Pamidronate—osteoporosis	0.000897	0.00176	CcSEcCtD
Nedocromil—Dizziness—Ethinyl Estradiol—osteoporosis	0.000892	0.00175	CcSEcCtD
Nedocromil—Anaphylactic shock—Estradiol—osteoporosis	0.00088	0.00172	CcSEcCtD
Nedocromil—Urticaria—Conjugated Estrogens—osteoporosis	0.000873	0.00171	CcSEcCtD
Nedocromil—Dizziness—Risedronate—osteoporosis	0.000869	0.0017	CcSEcCtD
Nedocromil—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000869	0.0017	CcSEcCtD
Nedocromil—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000869	0.0017	CcSEcCtD
Nedocromil—Vomiting—Ethinyl Estradiol—osteoporosis	0.000857	0.00168	CcSEcCtD
Nedocromil—Diarrhoea—Pamidronate—osteoporosis	0.000855	0.00167	CcSEcCtD
Nedocromil—Rash—Ethinyl Estradiol—osteoporosis	0.00085	0.00166	CcSEcCtD
Nedocromil—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000849	0.00166	CcSEcCtD
Nedocromil—Headache—Ethinyl Estradiol—osteoporosis	0.000845	0.00165	CcSEcCtD
Nedocromil—Hypersensitivity—Zoledronate—osteoporosis	0.000841	0.00165	CcSEcCtD
Nedocromil—Vomiting—Risedronate—osteoporosis	0.000836	0.00164	CcSEcCtD
Nedocromil—Rash—Risedronate—osteoporosis	0.000829	0.00162	CcSEcCtD
Nedocromil—Dermatitis—Risedronate—osteoporosis	0.000828	0.00162	CcSEcCtD
Nedocromil—Dizziness—Pamidronate—osteoporosis	0.000826	0.00162	CcSEcCtD
Nedocromil—Headache—Risedronate—osteoporosis	0.000824	0.00161	CcSEcCtD
Nedocromil—Asthenia—Zoledronate—osteoporosis	0.000819	0.0016	CcSEcCtD
Nedocromil—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00081	0.00159	CcSEcCtD
Nedocromil—Nausea—Ethinyl Estradiol—osteoporosis	0.000801	0.00157	CcSEcCtD
Nedocromil—Vomiting—Pamidronate—osteoporosis	0.000795	0.00156	CcSEcCtD
Nedocromil—Asthenia—Conjugated Estrogens—osteoporosis	0.000789	0.00154	CcSEcCtD
Nedocromil—Rash—Pamidronate—osteoporosis	0.000788	0.00154	CcSEcCtD
Nedocromil—Dermatitis—Pamidronate—osteoporosis	0.000787	0.00154	CcSEcCtD
Nedocromil—Dyspnoea—Estradiol—osteoporosis	0.000784	0.00154	CcSEcCtD
Nedocromil—Headache—Pamidronate—osteoporosis	0.000783	0.00153	CcSEcCtD
Nedocromil—Diarrhoea—Zoledronate—osteoporosis	0.000781	0.00153	CcSEcCtD
Nedocromil—Nausea—Risedronate—osteoporosis	0.000781	0.00153	CcSEcCtD
Nedocromil—Dyspepsia—Estradiol—osteoporosis	0.000774	0.00152	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Estradiol—osteoporosis	0.000759	0.00149	CcSEcCtD
Nedocromil—Fatigue—Estradiol—osteoporosis	0.000758	0.00148	CcSEcCtD
Nedocromil—Dizziness—Zoledronate—osteoporosis	0.000755	0.00148	CcSEcCtD
Nedocromil—Pain—Estradiol—osteoporosis	0.000752	0.00147	CcSEcCtD
Nedocromil—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000752	0.00147	CcSEcCtD
Nedocromil—Nausea—Pamidronate—osteoporosis	0.000742	0.00145	CcSEcCtD
Nedocromil—Dizziness—Conjugated Estrogens—osteoporosis	0.000727	0.00142	CcSEcCtD
Nedocromil—Vomiting—Zoledronate—osteoporosis	0.000726	0.00142	CcSEcCtD
Nedocromil—Rash—Zoledronate—osteoporosis	0.00072	0.00141	CcSEcCtD
Nedocromil—Gastrointestinal pain—Estradiol—osteoporosis	0.000719	0.00141	CcSEcCtD
Nedocromil—Dermatitis—Zoledronate—osteoporosis	0.000719	0.00141	CcSEcCtD
Nedocromil—Headache—Zoledronate—osteoporosis	0.000715	0.0014	CcSEcCtD
Nedocromil—Vomiting—Conjugated Estrogens—osteoporosis	0.000699	0.00137	CcSEcCtD
Nedocromil—Urticaria—Estradiol—osteoporosis	0.000699	0.00137	CcSEcCtD
Nedocromil—Abdominal pain—Estradiol—osteoporosis	0.000695	0.00136	CcSEcCtD
Nedocromil—Body temperature increased—Estradiol—osteoporosis	0.000695	0.00136	CcSEcCtD
Nedocromil—Rash—Conjugated Estrogens—osteoporosis	0.000693	0.00136	CcSEcCtD
Nedocromil—Dermatitis—Conjugated Estrogens—osteoporosis	0.000692	0.00136	CcSEcCtD
Nedocromil—Headache—Conjugated Estrogens—osteoporosis	0.000689	0.00135	CcSEcCtD
Nedocromil—Nausea—Zoledronate—osteoporosis	0.000678	0.00133	CcSEcCtD
Nedocromil—Nausea—Conjugated Estrogens—osteoporosis	0.000653	0.00128	CcSEcCtD
Nedocromil—Hypersensitivity—Estradiol—osteoporosis	0.000648	0.00127	CcSEcCtD
Nedocromil—Asthenia—Estradiol—osteoporosis	0.000631	0.00124	CcSEcCtD
Nedocromil—Diarrhoea—Estradiol—osteoporosis	0.000602	0.00118	CcSEcCtD
Nedocromil—Dizziness—Estradiol—osteoporosis	0.000582	0.00114	CcSEcCtD
Nedocromil—Vomiting—Estradiol—osteoporosis	0.000559	0.00109	CcSEcCtD
Nedocromil—Rash—Estradiol—osteoporosis	0.000555	0.00109	CcSEcCtD
Nedocromil—Dermatitis—Estradiol—osteoporosis	0.000554	0.00108	CcSEcCtD
Nedocromil—Headache—Estradiol—osteoporosis	0.000551	0.00108	CcSEcCtD
Nedocromil—Nausea—Estradiol—osteoporosis	0.000522	0.00102	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—ADCY5—osteoporosis	0.000469	0.001	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000464	0.000988	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CNR2—osteoporosis	0.000463	0.000986	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—FGA—osteoporosis	0.00046	0.00098	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—ADCY5—osteoporosis	0.000453	0.000965	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PTHLH—osteoporosis	0.000443	0.000943	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—BMP2—osteoporosis	0.000443	0.000943	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ATIC—osteoporosis	0.00044	0.000937	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PNP—osteoporosis	0.00044	0.000937	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—PSMA2—osteoporosis	0.000439	0.000935	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—PSMA5—osteoporosis	0.000439	0.000935	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—WNT1—osteoporosis	0.000435	0.000927	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—PTHLH—osteoporosis	0.000434	0.000923	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—FGB—osteoporosis	0.000433	0.000923	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PTHLH—osteoporosis	0.000428	0.000911	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—BMP2—osteoporosis	0.000428	0.000911	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—LRP5—osteoporosis	0.000425	0.000904	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MGLL—osteoporosis	0.000424	0.000904	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SOST—osteoporosis	0.000424	0.000903	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	0.000423	0.0009	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—FGB—osteoporosis	0.000418	0.000891	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PSMA2—osteoporosis	0.000418	0.000891	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PSMA5—osteoporosis	0.000418	0.000891	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—P4HB—osteoporosis	0.000416	0.000887	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—LRP5—osteoporosis	0.000414	0.000882	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—LRP6—osteoporosis	0.000406	0.000865	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PTH—osteoporosis	0.000405	0.000862	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PSMA5—osteoporosis	0.000404	0.00086	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PSMA2—osteoporosis	0.000404	0.00086	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IRAK3—osteoporosis	0.000401	0.000853	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RAP1A—osteoporosis	0.000398	0.000848	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—LRP6—osteoporosis	0.000396	0.000844	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CNR2—osteoporosis	0.000395	0.00084	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PTHLH—osteoporosis	0.000394	0.000839	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000393	0.000837	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—ADCY5—osteoporosis	0.000392	0.000834	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RPL24—osteoporosis	0.00039	0.000831	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—LTF—osteoporosis	0.00039	0.000831	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CALCA—osteoporosis	0.00039	0.00083	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NFATC1—osteoporosis	0.000388	0.000827	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—IL6—osteoporosis	0.000385	0.000821	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DKK1—osteoporosis	0.000385	0.00082	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTH1R—osteoporosis	0.000383	0.000817	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CALCR—osteoporosis	0.000383	0.000817	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CALCA—osteoporosis	0.000382	0.000813	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—POMC—osteoporosis	0.00038	0.00081	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CALCA—osteoporosis	0.000376	0.000802	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CA2—osteoporosis	0.000374	0.000796	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—OXCT1—osteoporosis	0.000374	0.000796	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—WNT1—osteoporosis	0.000371	0.00079	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—POMC—osteoporosis	0.000367	0.000782	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ACTG1—osteoporosis	0.000366	0.000781	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—MGLL—osteoporosis	0.000364	0.000776	CbGpPWpGaD
Nedocromil—HSP90AA1—Influenza Infection—TGFB1—osteoporosis	0.000364	0.000774	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—FGA—osteoporosis	0.000361	0.000769	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—ADCY5—osteoporosis	0.000356	0.000758	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—KL—osteoporosis	0.000354	0.000755	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KL—osteoporosis	0.000354	0.000754	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—TGFB1—osteoporosis	0.000354	0.000753	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—POMC—osteoporosis	0.000353	0.000753	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CALCA—osteoporosis	0.000347	0.000738	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—POMC—osteoporosis	0.000345	0.000735	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KL—osteoporosis	0.000342	0.000728	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—osteoporosis	0.000342	0.000728	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ACP5—osteoporosis	0.000338	0.000721	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6R—osteoporosis	0.000337	0.000717	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PTHLH—osteoporosis	0.000336	0.000715	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—BMP2—osteoporosis	0.000336	0.000715	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TLN1—osteoporosis	0.000335	0.000713	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—POMC—osteoporosis	0.000333	0.00071	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—FGB—osteoporosis	0.000328	0.000699	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6R—osteoporosis	0.000325	0.000693	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—IL6—osteoporosis	0.000322	0.000687	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PSMA5—osteoporosis	0.000317	0.000675	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PSMA2—osteoporosis	0.000317	0.000675	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6R—osteoporosis	0.000316	0.000673	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TPI1—osteoporosis	0.000315	0.00067	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—IDH2—osteoporosis	0.00031	0.00066	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—RAP1A—osteoporosis	0.000306	0.000652	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MGLL—osteoporosis	0.000305	0.000649	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CTSK—osteoporosis	0.000304	0.000647	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NFATC1—osteoporosis	0.000299	0.000636	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LRP5—osteoporosis	0.000297	0.000633	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—P4HB—osteoporosis	0.000296	0.00063	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CALCA—osteoporosis	0.000295	0.000629	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP27A1—osteoporosis	0.000291	0.00062	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—GAPDH—osteoporosis	0.00029	0.000618	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—P4HB—osteoporosis	0.000289	0.000615	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—POMC—osteoporosis	0.000288	0.000614	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LRP6—osteoporosis	0.000284	0.000606	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ACP5—osteoporosis	0.000283	0.000604	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTH—osteoporosis	0.000281	0.000598	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AGER—osteoporosis	0.000279	0.000593	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—ADCY5—osteoporosis	0.000278	0.000591	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ADCY5—osteoporosis	0.000277	0.000591	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RAP1A—osteoporosis	0.000276	0.000587	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NFATC1—osteoporosis	0.000276	0.000587	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—DKK1—osteoporosis	0.000274	0.000583	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CNR2—osteoporosis	0.000274	0.000583	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000272	0.00058	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—ADCY5—osteoporosis	0.000271	0.000578	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—LEP—osteoporosis	0.000269	0.000573	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NFATC1—osteoporosis	0.000269	0.000573	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SPP1—osteoporosis	0.000268	0.000571	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KL—osteoporosis	0.000268	0.000571	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ADCY5—osteoporosis	0.000268	0.00057	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DKK1—osteoporosis	0.000267	0.000569	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—WNT1—osteoporosis	0.000264	0.000561	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TPI1—osteoporosis	0.000263	0.000561	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—POMC—osteoporosis	0.000262	0.000557	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SPP1—osteoporosis	0.000259	0.000552	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—WNT1—osteoporosis	0.000257	0.000548	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FGA—osteoporosis	0.000256	0.000546	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6R—osteoporosis	0.000255	0.000544	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGA—osteoporosis	0.00025	0.000533	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—P4HB—osteoporosis	0.000248	0.000528	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—ADCY5—osteoporosis	0.000247	0.000525	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—IL6—osteoporosis	0.000244	0.00052	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PSMA5—osteoporosis	0.000244	0.00052	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PSMA2—osteoporosis	0.000244	0.00052	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GAPDH—osteoporosis	0.000243	0.000518	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IRS2—osteoporosis	0.000243	0.000517	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IRS2—osteoporosis	0.000243	0.000517	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TLN1—osteoporosis	0.00024	0.000512	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—LEP—osteoporosis	0.000237	0.000506	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—RAP1A—osteoporosis	0.000237	0.000504	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IRS2—osteoporosis	0.000234	0.000499	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTHLH—osteoporosis	0.000233	0.000495	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—BMP2—osteoporosis	0.000233	0.000495	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—LEP—osteoporosis	0.000229	0.000488	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ENO1—osteoporosis	0.000229	0.000487	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGB—osteoporosis	0.000228	0.000485	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ESR1—osteoporosis	0.000227	0.000483	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6R—osteoporosis	0.000226	0.00048	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PSMA5—osteoporosis	0.000225	0.00048	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PSMA2—osteoporosis	0.000225	0.00048	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—IL6—osteoporosis	0.000224	0.000478	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PSMA2—osteoporosis	0.00022	0.000468	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PSMA5—osteoporosis	0.00022	0.000468	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ESR1—osteoporosis	0.000219	0.000466	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IRS1—osteoporosis	0.000212	0.000452	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IRS1—osteoporosis	0.000212	0.000451	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ADCY5—osteoporosis	0.00021	0.000448	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CALCA—osteoporosis	0.00021	0.000447	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—P4HB—osteoporosis	0.000207	0.000441	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KL—osteoporosis	0.000206	0.00044	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CALCA—osteoporosis	0.000205	0.000436	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IRS1—osteoporosis	0.000205	0.000436	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—POMC—osteoporosis	0.000204	0.000434	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SPP1—osteoporosis	0.000203	0.000433	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTH—osteoporosis	0.000201	0.000429	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—POMC—osteoporosis	0.0002	0.000425	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6R—osteoporosis	0.000199	0.000424	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6R—osteoporosis	0.000199	0.000424	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RAP1A—osteoporosis	0.000198	0.000422	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—POMC—osteoporosis	0.000197	0.000419	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CNR2—osteoporosis	0.000196	0.000418	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IGF1—osteoporosis	0.000196	0.000418	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NFATC1—osteoporosis	0.000193	0.000411	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6R—osteoporosis	0.000192	0.000409	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DKK1—osteoporosis	0.000192	0.000408	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ENO1—osteoporosis	0.000191	0.000408	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—KL—osteoporosis	0.000191	0.000406	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IGF1—osteoporosis	0.000189	0.000403	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PSMA5—osteoporosis	0.000189	0.000402	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PSMA2—osteoporosis	0.000189	0.000402	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KL—osteoporosis	0.000186	0.000396	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—WNT1—osteoporosis	0.000185	0.000393	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IRS2—osteoporosis	0.000184	0.000392	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—POMC—osteoporosis	0.000181	0.000386	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—LEP—osteoporosis	0.00018	0.000383	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGA—osteoporosis	0.00018	0.000382	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6R—osteoporosis	0.000177	0.000377	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ESR1—osteoporosis	0.000172	0.000366	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTHLH—osteoporosis	0.000167	0.000356	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—BMP2—osteoporosis	0.000167	0.000356	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—IL6—osteoporosis	0.000166	0.000353	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGB—osteoporosis	0.000163	0.000348	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AGER—osteoporosis	0.000162	0.000346	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ADCY5—osteoporosis	0.000162	0.000344	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IRS1—osteoporosis	0.00016	0.000342	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PSMA5—osteoporosis	0.000158	0.000336	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PSMA2—osteoporosis	0.000158	0.000336	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—POMC—osteoporosis	0.000155	0.000329	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP19A1—osteoporosis	0.000153	0.000326	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6R—osteoporosis	0.000151	0.000321	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6—osteoporosis	0.00015	0.000319	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ADCY5—osteoporosis	0.000149	0.000318	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF1—osteoporosis	0.000149	0.000317	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CALCA—osteoporosis	0.000147	0.000313	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ADCY5—osteoporosis	0.000146	0.00031	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6—osteoporosis	0.000145	0.000309	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IRS2—osteoporosis	0.000141	0.000301	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SPP1—osteoporosis	0.000141	0.0003	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6—osteoporosis	0.000141	0.0003	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MYC—osteoporosis	0.000138	0.000295	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MTHFR—osteoporosis	0.000137	0.000292	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KL—osteoporosis	0.000133	0.000284	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TGFB1—osteoporosis	0.000133	0.000284	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IRS2—osteoporosis	0.000131	0.000278	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IRS2—osteoporosis	0.000127	0.000271	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ADCY5—osteoporosis	0.000125	0.000266	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—LEP—osteoporosis	0.000125	0.000266	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GPX1—osteoporosis	0.000125	0.000265	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—osteoporosis	0.000124	0.000265	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MYC—osteoporosis	0.000124	0.000264	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IRS1—osteoporosis	0.000123	0.000263	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ESR1—osteoporosis	0.000119	0.000254	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MYC—osteoporosis	0.000118	0.000251	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TGFB1—osteoporosis	0.000118	0.00025	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6R—osteoporosis	0.000116	0.000247	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—MTHFR—osteoporosis	0.000115	0.000245	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IRS1—osteoporosis	0.000114	0.000243	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MYC—osteoporosis	0.000114	0.000242	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6—osteoporosis	0.000114	0.000242	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TGFB1—osteoporosis	0.000114	0.000242	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IRS1—osteoporosis	0.000111	0.000237	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—POMC—osteoporosis	0.000107	0.000228	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6R—osteoporosis	0.000107	0.000228	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADCY5—osteoporosis	0.000105	0.000223	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6R—osteoporosis	0.000104	0.000223	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF1—osteoporosis	0.000103	0.000219	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SPP1—osteoporosis	0.000101	0.000215	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6—osteoporosis	0.0001	0.000214	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—POMC—osteoporosis	9.2e-05	0.000196	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IRS2—osteoporosis	9.15e-05	0.000195	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LEP—osteoporosis	8.95e-05	0.000191	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MYC—osteoporosis	8.93e-05	0.00019	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TGFB1—osteoporosis	8.91e-05	0.00019	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6—osteoporosis	8.87e-05	0.000189	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6—osteoporosis	8.86e-05	0.000189	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1B—osteoporosis	8.83e-05	0.000188	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6—osteoporosis	8.56e-05	0.000182	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ESR1—osteoporosis	8.55e-05	0.000182	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IRS1—osteoporosis	7.98e-05	0.00017	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6—osteoporosis	7.88e-05	0.000168	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—POMC—osteoporosis	7.69e-05	0.000164	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6R—osteoporosis	7.5e-05	0.00016	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF1—osteoporosis	7.4e-05	0.000158	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6—osteoporosis	6.72e-05	0.000143	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MYC—osteoporosis	6.35e-05	0.000135	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TGFB1—osteoporosis	6.33e-05	0.000135	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MYC—osteoporosis	6.19e-05	0.000132	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TGFB1—osteoporosis	6.18e-05	0.000132	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6—osteoporosis	5.17e-05	0.00011	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6—osteoporosis	4.77e-05	0.000102	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6—osteoporosis	4.65e-05	9.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MYC—osteoporosis	4.44e-05	9.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFB1—osteoporosis	4.43e-05	9.44e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6—osteoporosis	3.34e-05	7.12e-05	CbGpPWpGaD
